United Therapeutics (UTHR) Deferred Taxes (2009 - 2026)

United Therapeutics' (UTHR) quarterly Deferred Taxes came in at $25.9 million in Q1 2026, down 14.75% quarter-over-quarter from $30.4 million in Q3 2012.

United Therapeutics (UTHR) Deferred Taxes (2009 - 2026) Analysis & Trends

United Therapeutics has disclosed Deferred Taxes across 5 years of filings, most recently posting $25.9 million for Q1 2026.

  • Deferred Taxes for Q1 2026 came in at $25.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $87.3 million (down 7.7% YoY), and the FY2025 annual result was $97.7 million, up 252.42% from the prior year.
  • Deferred Taxes came in at $25.9 million for Q1 2026 at United Therapeutics, down from $30.4 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $25.9 million in Q1 2026 to a low of $25.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -22.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 34.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 25.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 14,341.73
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -61.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -8.79 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 19.33 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -13.98 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 25.90 Mn
Sep 30, 2012 30.38 Mn
Jun 30, 2012 30.97 Mn
Mar 31, 2012 33.18 Mn
Sep 30, 2011 19.23 Mn
Jun 30, 2011 35.72 Mn
Mar 31, 2011 10.44 Mn
Dec 31, 2010 -5.04 Mn
Sep 30, 2010 18.00 Mn
Jun 30, 2010 19.21 Mn
Mar 31, 2010 9.75 Mn
Dec 31, 2009 -1.75 Mn
Sep 30, 2009 -2.89 Mn